DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in access to its products for those treating ...
Dexcom announces the FDA approval of its over-the-counter glucose monitor, which will provide access to new medical resources for those lacking insurance. For those diagnosed with Type 2 Diabetes, a ...
The U.S. spends $413 billion dollars each year on diabetes-related care, meaning that diabetic patients now account for one of every four healthcare dollars spent in the country. The first step in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results